If we combine tau measurements in TBS and SI in each group, including phosphorylated and non-phosphorylated tau species, it becomes even more evident that total tau content appears to be substantially more abundant in AD brain than in controls, CBD, PSP, and PiD. The gene discussed is MTA2; the disease is Alzheimer disease.